Merck & Co., Inc. (MRK): A Bull Case Theory

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Long-Term Pick. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)’s share was trading at $85.67 as of Feb 12th. MRK’s trailing and forward P/E were 12.71 and 9.50 respectively according to Yahoo Finance.

20 Lowest Paying Countries for Doctors

A doctor in a white coat discussing clinical trial results with a patient in an oncology practice.

Merck’s fair price estimate has been updated to $188, reflecting...